Everything tagged "dividend" across research, earnings, and macro.
108 articles
Northern Trust is executing well, with strong 1Q26 growth, margin expansion, and a solid balance sheet. The stock looks like a quality Hold leaning Buy on weakness rather than a clear bargain.
Tractor Supply is digesting a temporary earnings slowdown, but its needs-based demand, store growth, and strong cash generation remain intact. The stock looks like a selective Buy on weakness rather than a broken retailer.
UnitedHealth is still a healthcare giant, but 2025 exposed a sharp margin reset driven by medical cost inflation and OptumHealth weakness. The stock looks like a Buy for medium-term investors if management can keep the 2026 repair on track.
Alcon is a steady eye-care compounder with recurring revenue, new product momentum, and a disciplined balance sheet. The stock looks constructive, but not deeply cheap, after solid FY2025 growth and a still-elevated valuation.
CCEP delivered record 2025 revenue, margin expansion, and strong free cash flow, reinforcing its case as a steady compounder. The main debate is valuation, not business quality, with buybacks and dividends supporting returns.
Netstreit is a high-occupancy net lease REIT with solid AFFO growth, improving credit quality, and disciplined capital recycling. The report is constructive, but valuation looks closer to fair value than a clear bargain.
Bank of Hawaii looks like a quality regional bank with improving earnings, rising net interest margin, and clean credit. The stock appears close to fair value, making it more of a selective Buy on pullbacks than a deep-value opportunity.
GlobalFoundries is a balanced Hold with real upside from specialty semiconductors, automotive, and silicon photonics. The stock’s premium valuation leaves less room for error as near-term revenue guidance softens.
Globe Life is a disciplined insurer with steady premium growth, strong underwriting margins, and meaningful buyback support. The stock still looks undervalued relative to its earnings power and 2026 guidance.
Equinor looks like a medium-term Buy for investors seeking cash-generating energy exposure with disciplined capital returns. The report highlights resilient cash flow, a $4B CapEx cut, and a low-cost portfolio that still screens attractively despite softer recent earnings.
BP looks like a medium-term Buy as improving operations, stronger cash generation, and a disciplined reset outweigh commodity volatility. The market still discounts the turnaround, but BP’s simpler strategy and self-help plan are gaining traction.
Petrobras looks undervalued on earnings and cash flow, with strong production growth and high refinery utilization supporting the case. The main offset is Brazil-specific political and pricing risk, which can keep the multiple compressed.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator